Schlatterer K., Esmaeili A., Chandra A., Hofmann D., Lerch A., Demirhan I., Schlatterer B., Chandra P. (1997) Low molecular weight proteins secreted by peritoneal macrophages obtained from 2,3,7,8-tetrabromodibenzo-p-dioxin-treated NMRI mice Electrophoresis, 18, 136-141
Newton C.J., Schlatterer K., Stalla G.K., von Angerer E., Wowra B. (1998) Pharmacological enhancement of radiosurgery response: studies of an in vitro model J. Radiosurgery, 1, 51-56
Schlatterer K., Krauter G., Schlatterer B., Chandra P., Hecker E. (1999) Mechanistically different acting tumor promoters induce consistant qualitative and quantitative changes in protein expression patterns of murine epidermis Anticancer Res., 19, 385-396
Schlatterer K., Krauter G., Schlatterer B., Chandra P., Hecker E. (1999) A novel protein (p10) induced by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and other hyperplasiogenic tumor-promoting and non-promoting agents in murine epidermis Anticancer Res., 19, 397-402
Schlatterer K., Orth M., Fitzner R., Tauber R. (2000) Genotyping of factor V Leiden in research samples: a methodological comparison between allele-specific PCR (PCR-SSP) and the LightCycler technology Biochemica, 1, 31-34
Schlatterer K., Esmaeili A., Chandra A., Martin B., Demirhan I., Schlatterer B., Chandra P. (2000) Peritoneal macrophages from 17-ethinylestradiol-treated NMRI mice secrete transformation-specific low molecular weight proteinsAnticancer Res., 20, 283-288
Schlatterer K., Schlatterer B., Krauter G., Hecker E., Chandra P. (2000) A novel polypeptide p10 expressed in tumor-promoter-treated murine epidermis and in untreated neonatal murine epidermis Anticancer Res., 20, 289-292
Orth M., Westphal S., Dierkes J., Luley C, Schlatterer K. (2001) Rapid factor XII (46CT) genotyping by fluorescence resonance energy transfer in patients with coronary artery disease or thrombophilia Clin.Chem., 47, 1117-1119
Baeker R., Haebel S., Schlatterer K., Schlatterer B. (2002) Lipocalin-type prostaglandin D synthase in milk: a new biomarker for bovine mastitis Prostaglandins Other Lipid Mediat., 67, 75-88
Seitz V., Clermont A., Wedde M., Hummel M., Vilcinskas A., Schlatterer K., Podsiadlowski L (2003) Identification of immunorelevant genes from greater wax moth (Galleria mellonella) by a subtractive hybridisation approach Dev. Comp. Immunol., 27, 207-15
Stendel R., Scheurer L., Schlatterer K., Gminski R., Möhler H (2004) Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors Anticancer Res., 24, 631-638
Schlatterer B., Baeker R., Schlatterer K. (2004) Improved purification of ß-lactoglobulin from acid whey by means of ceramic hydroxyapatite chromatography with sodium fluoride as a displacer J. Chromatography B, 807, 223-228
Schlatterer K., Gminski R., Schlatterer J., Hecker E., Chandra P., Schlatterer B., Krauter G., Chandra A. (2005) 12-O-Retinoyl-phorbol-13-acetate (RPA) behaves like a retinoid-derivative in binding to retinol-binding protein – a correlation with its specific action as an incomplete tumor promoter? Anticancer Res., 25, 3355-3366
Schlatterer K., Perschel F.H., Landt O., Fitzner R.G., Tauber R. (2005) Rapid screening of the vitamin D receptor Bsm I gene polymorphism by real-time PCR using the LightCycler Instrument Biochemica, 3, 7-8
Remondini D., Nylund R., Reivinen J., Poulletier de Gannes F., Veyret B., Lagroye.I., Haro E., Trillo MA., Capri M., Schlatterer K., Gminski R., Fitzner R., Tauber R., Schuderer J., Kuster N., Leszczynski D., Bersani F., Maercker C. (2006) Gene expression changes in human cells after exposure to mobile phone microwaves Proteomics, 6, 4745-4754
Schlatterer JC., Baeker R., Schlatterer B., Klose J., Kehler W., Schlatterer K. (2006) Purification of prostaglandin D synthase by ceramic and size exclusion Chromatography Prostaglandins & other Lipid Mediators, 81, 80–89
Esmaeili A., Schlatterer K., Demirhan I., Schlatterer B., Nauck M., Chandra P., Chandra A. (2006) Tumorigenic potential and the molecular mechanism of the carcinogenic effect exerted by 2-nitroanisole Anticancer Res., 26, 4203-4212
Stendel R., Scheurer L., Schlatterer K., Stalder U., Pfirrmann RW., Fiss I., Möhler H., Bigler L. (2007) Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients Clin. Pharmacokinet., 46, 513-524
Esmaeili A., Chandra T., Schlatterer K. (2007) Evaluation of carcinogenic potential of 17alpha-ethinylestradiol in a host-mediated in vivo/in vitro assay system Anticancer Res., 27, 2197-2207
